This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's What Key Metrics Tell Us About Clarivate (CLVT) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Clarivate (CLVT) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Clarivate PLC (CLVT) Q2 Earnings Match Estimates
by Zacks Equity Research
Clarivate (CLVT) delivered earnings and revenue surprises of 0.00% and +5.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CoStar Group (CSGP) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CoStar (CSGP) delivered earnings and revenue surprises of +21.43% and +1.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Serve Robotics Surges 103% in a Month: What Should Investors Do?
by Zacks Equity Research
SERV accelerates growth with fleet and new market expansion. Yet, persistent losses and supply-chain headwinds limit near-term growth visibility.
Clarivate (CLVT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clarivate PLC (CLVT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Clarivate (CLVT) delivered earnings and revenue surprises of 16.67% and 3.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Booking Holdings to Report Q1 Earnings: What Should Investors Do?
by Zacks Equity Research
BKNG faces headwinds in Q1 with Easter timing shift and FX pressures offsetting marketing initiatives. You can hold the stock or wait for a better entry point.
Snap to Report Q1 Earnings: Key Metrics and Expectations to Watch
by Zacks Equity Research
SNAP's Q1 revenues are likely to have benefited from Snapchat+ growth. However, operating costs are likely to have increased due to a shift in marketing expenses.
Earnings Preview: Unisys (UIS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Unisys (UIS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Charter Communications to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CHTR's rural buildout is likely to have supported Q1 growth, partly offset by wildfire-related loss in passings.
Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Clarivate (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Compared to Estimates, Clarivate (CLVT) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Clarivate (CLVT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Clarivate PLC (CLVT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Clarivate (CLVT) delivered earnings and revenue surprises of 5% and 0.75%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Unisys (UIS) Tops Q4 Earnings Estimates
by Zacks Equity Research
Unisys (UIS) delivered earnings and revenue surprises of 65% and 3.30%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for Clarivate (CLVT) Q4 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Clarivate (CLVT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Fair Isaac (FICO) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Fair Isaac (FICO) delivered earnings and revenue surprises of -6.76% and 3.25%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Accenture Stock Rises 17% in 6 Months: How Should Investors Play It?
by Arghyadeep Bose
Given the surge in ACN's share price, we evaluate its current position to find out whether it offers a good investment opportunity now.
Does Clarivate (CLVT) Have the Potential to Rally 29.13% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 29.1% in Clarivate (CLVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Dynatrace's 16% Rise in 6 Months Justify Holding on to the Stock?
by Zacks Equity Research
The DT stock gains from AI-driven growth and strong partnerships. Yet, challenges in customer acquisition and sales productivity are concerning.
Here's Why It is Appropriate to Retain Roper Stock Right Now
by Zacks Equity Research
ROP gains from solid momentum across its segments, accretive acquisitions and shareholder-friendly policies.
Clarivate (CLVT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clarivate PLC (CLVT) Matches Q3 Earnings Estimates
by Zacks Equity Research
Clarivate (CLVT) delivered earnings and revenue surprises of 0% and 2.78%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
What Analyst Projections for Key Metrics Reveal About Clarivate (CLVT) Q3 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Clarivate (CLVT) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Evolent Health (EVH) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Radware (RDWR) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Radware (RDWR) delivered earnings and revenue surprises of 15% and 1.59%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?